Login / Signup

Patterns of Biomarker Use in Cancer Treatment Among Medical Oncologists in the Philippines.

Lance Isidore Garcenila CatedralHarold Nathan TanAlfredo V ChuaDanielle Benedict Leoncio SacdalanDennis Lee Sacdalan
Published in: JCO global oncology (2021)
Medical oncologists in the Philippines would use biomarkers in treating breast, colorectal, and lung cancers if these were clinically indicated and if cost were not a factor. Financial difficulty experienced by patients was the most commonly cited barrier to biomarker use.
Keyphrases
  • end stage renal disease
  • healthcare
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • palliative care
  • childhood cancer